Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher than an economic research group recommends, but the company says most patients will pay very little themselves.
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?
Durante varios años ha existido en Sudáfrica una pastilla que se debe tomar todos los días para prevenir el virus. Ahora existe una inyección cada dos meses, un método mucho más accesible, pero aún no se consigue en el África subsahariana.
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Covid Boosters
Who should get a Covid booster, and when? We answer the big questions.
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertain
An injection every two months rather than a daily pill could shield many more women from the virus, but it is unavailable in places that need it most.
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacks
The company was accused of illegally paying doctors to prescribe its drugs over those of its rivals.
La salud mental es política
Hay una crisis de salud mental en EE. UU. Y el primer paso para resolverla es hacer preguntas incómodas a quienes están en el poder.
Monkeypox Appears to Recede, but Risks and Uncertainties Linger
Scientists do not yet know how well the vaccine and the drug used to treat the infection are working. Two new trials will provide answers.
Weekly Health Quiz: Broken Hearts, Anxiety and Exercise
Test your knowledge of this week’s health news.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.